# Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

> **NCT04678388** · PHASE1 · UNKNOWN · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 24 (estimated)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **DRUG:** Reference drug
- **DRUG:** Test drug 1
- **DRUG:** Test drug 2

## Key facts

- **NCT ID:** NCT04678388
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-29
- **Primary completion:** 2020-12-12
- **Final completion:** 2020-12-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2020-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04678388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04678388, "Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04678388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*